Bruker Corporation - Common Stock (NQ:BRKR)

58.97 +1.05 (+1.81%)

Delayed Quote Updated: 1:47 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Bruker Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution

October 06, 2026

From Bruker Corporation

Via Business Wire

Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research

September 28, 2026

From Bruker Corporation

Via Business Wire

Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley

September 21, 2026

From Bruker Corporation

Via Business Wire

Bruker Corporation to Present at Upcoming Investor Conferences

September 08, 2026

From Bruker Corporation

Via Business Wire

BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion

September 04, 2026

From Bruker Corporation

Via Business Wire

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

August 11, 2026

From Bruker Corporation

Via Business Wire

Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development

August 10, 2026

From Bruker Corporation

Via Business Wire

Bruker Reports Second Quarter 2026 Financial Results

August 04, 2026

From Bruker Corporation

Via Business Wire

Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

July 24, 2026

From Bruker Corporation

Via Business Wire

Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood

July 15, 2026

From Bruker Corporation

Via Business Wire

Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026

June 04, 2026

From Bruker Corporation

Via Business Wire

Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry

June 02, 2026

From Bruker Corporation

Via Business Wire

Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology

June 01, 2026

From Bruker Corporation

Via Business Wire

Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI

May 26, 2026

From Bruker Corporation

Via Business Wire

Bruker Reports First Quarter 2026 Financial Results

May 06, 2026

From Bruker Corporation

Via Business Wire

Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast

April 24, 2026

From Bruker Corporation

Via Business Wire

Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026

April 17, 2026

From Bruker Corporation

Via Business Wire

Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026

April 17, 2026

From Bruker Corporation

Via Business Wire

Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management

April 17, 2026

From Bruker Corporation

Via Business Wire

Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026

April 13, 2026

From Bruker Corporation

Via Business Wire

Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research

April 07, 2026

From Bruker Corporation

Via Business Wire

Bruker Announces Appointment of Thierry Bernard to its Board of Directors

April 01, 2026

From Bruker Corporation

Via Business Wire

PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge

March 31, 2026

From Bruker Corporation

Via Business Wire

Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR

February 25, 2026

From Bruker Corporation

Via Business Wire

Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications

February 24, 2026

From Bruker Corporation

Via Business Wire

Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum

February 23, 2026

From Bruker Corporation

Via Business Wire

Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology

February 23, 2026

From Bruker Corporation

Via Business Wire

Bruker Reports Fourth Quarter and Full Year 2025 Financial Results

February 12, 2026

From Bruker Corporation

Via Business Wire

Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC

February 09, 2026

From Bruker Corporation

Via Business Wire

Chemspeed and SciY Announce Self‑Driving Laboratory Platform Integrating Automation, Analytics and AI Orchestration

February 09, 2026

From Bruker Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.